昆虫抗菌肽的生物学特点及药物研发进展

昆虫抗菌肽是由昆虫细胞特定基因编码、由细胞核糖体合成的,具有体液免疫功能的一类碱性多肽,对细菌、真菌、病毒和原虫,甚至癌细胞都具有杀伤作用,有望开发成为新一代的抗菌药物。随着抗菌肽家族的不断扩大,其各方面的研究也日益深入。简要综述了昆虫抗菌肽的种类及结构特点、作用机制、生物活性、构效关系、药物开发情况。     

抗菌肽临床应用前景分析

抗菌肽是生物天然免疫的重要组成部分,几乎存在于所有种类的生物中。目前已发现的抗菌肽超过2 000种。抗菌肽具有广谱抗菌活性,对大多数革兰氏阳性菌、革兰氏阴性菌和真菌具有强大的抑制作用（包括多药物耐受微生物）,而且这种作用具有较好的选择性。这些特点使抗菌肽具有成为抗感染药物的重大潜力;但抗菌肽的临床应用也面临着一些困难,如抗菌肽大量生产、体内稳定性、微生物耐受等。对抗菌肽临床应用面临的问题及正在进行临床研究和临床前研究的抗菌肽做一简要综述。     

昆虫抗菌肽的生理活性及其转基因应用前景

昆虫抗菌肽是昆虫免疫后存在于血淋巴中的一类活性肽。根据分子的结构可分为 5类 :天蚕素类、昆虫防御素、富含脯氨酸或精氨酸的抗菌肽、富含甘氨酸的抗菌肽、抗真菌肽。且具有广谱的抗菌、抗病毒、抑制肿瘤的生物活性。概述了昆虫抗菌肽的基因的克隆与表达及转基因研究方面的进展 ,并展望了抗菌肽在基因工程中的应用前景     

昆虫抗菌肽对病原微生物作用的研究进展

在诱导和非诱导情况下,昆虫能产生各种类型的具有体液免疫功能的小分子物质-抗菌肽,参与机体对入侵病原微生物的免疫应答反应,构成了机体独特的免疫系统和免疫机制。这类抗菌肽或抗菌蛋白也存在于其它动物。研究表明,抗菌肽对细菌、真菌、病毒和原虫都具有作用,甚至对癌细胞也具有杀伤作用。随着抗菌肽家族的不断扩大,其结构研究的深入,相继提出了一些崭新的杀菌方式和作用机制。本文从目前国内外这方面的研究入手,分析各抗菌肽的作用特点、杀菌作用模式,展望了基因工程及临床应用的前景。     

昆虫抗茵肽的生理活性及其转基因应用前景

昆虫抗菌肽是昆虫免疫后存在于血淋巴中的一类活性肽.根据分子的结构可分为5类天蚕素类、昆虫防御素、富含脯氨酸或精氨酸的抗菌肽、富含甘氨酸的抗菌肽、抗真菌肽.且具有广谱的抗菌、抗病毒、抑制肿瘤的生物活性.概述了昆虫抗菌肽的基因的克隆与表达及转基因研究方面的进展,并展望了抗菌肽在基因工程中的应用前景.     

昆虫抗菌肽结构、性质和基因调控

昆虫抗菌肽是昆虫先天免疫系统中非常重要的一类效应分子。昆虫抗菌肽带正电荷,分子量小,大多数少于100个氨基酸残基。根据结构可以将昆虫抗菌肽分为一些不同的家族。昆虫抗菌肽不同的抗菌谱表明,它具有不同的作用机制。以果蝇为模式生物研究表明,昆虫抗菌肽的基因调控涉及到多个信号通路及大量的信号分子。     

抗菌肽的研究现状和挑战

抗菌肽(AMPs)广泛存在于生物体内,可以协助机体抵御外源微生物的侵害,是生物体先天性防御系统中的重要组成成分。普遍认为,抗菌肽通过膜损伤机制,破坏微生物细胞膜或细胞壁的完整性,达到抑杀微生物的目的。然而,越来越多的证据表明抗菌肽还存在非膜损伤机制,作用于胞内靶位点杀伤细胞。由于其独特的作用机制及广谱抗菌活性,抗菌肽被应用于各行各业。但是,抗菌肽的推广应用也面临着诸多难题,如生物稳定性、抗菌活性的维持和微生物耐受性等。主要对抗菌肽的种类、作用机制、微生物对抗菌肽耐受性的产生机制及抗菌肽的应用和挑战进行综述。     

抗菌肽的研究进展

抗菌肽是一类抗细菌、真菌、病毒、寄生虫及肿瘤细胞的小分子多肽,是生物抵御自然界中有害微生物侵染的重要因素,且具抗菌谱广、无免疫原性、作用机制独特、耐热性好等特性,有望成为抗生素的替代品。本文着重介绍了抗菌肽的性质、种类、作用机理等方面的研究进展,同时对其应用、目前存在的问题进行了讨论。     

昆虫抗菌肽和抗真菌肽结构与功能的关系及分子设计

在对GenBank和EMBL数据库中登录的昆虫抗微生物肽 (antimicrobial peptide, AMP), 即昆虫抗菌肽 (antibacterial peptide) 和抗真菌肽 (antifungal peptide, AFP) 进行归类整理的基础上,对天蚕素族(cecropins )抗菌肽结构与功能的关系及人工改造的分子设计策略,特别是对目前新发现的一些昆虫抗真菌肽的已知结构与功能关系的研究进展、存在问题等进行了简要介绍和分析,为从事昆虫抗微生物肽的理论研究和发展新型抗生素药物提供了必要的信息。     

昆虫抗菌肽对肿瘤细胞的抑制作用研究进展

昆虫抗菌肽(antimicrobial peptide,AMPs)是一类昆虫先天免疫系统中十分重要的效应因子,它分子量小、热稳定,并且具有广谱抗菌性,能够抑制、杀死多种细菌、真菌.近几年来,由于昆虫抗菌肽具有抗肿瘤的活性且其不具有抗原性而受到研究者的广泛关注.昆虫种类多、分布广,因此昆虫抗菌肽具有很高的开发潜力和实际应用价值.但是,目前对于昆虫抗菌肽抗肿瘤能力的研究尚不够深入,对其作用机制还没有一套准确并且系统的理论.现在普遍认为昆虫抗菌肽的抗肿瘤机制与其抗菌机制类似,可以分为破坏细胞膜机制以及非破坏细胞膜机制,并且同一种昆虫抗菌肽可以通过多种方式来抑制甚至杀死肿瘤细胞,但是对正常真核细胞无明显的毒副作用.相较于传统化疗药物的无差别杀伤,昆虫抗菌肽在肿瘤治疗领域有着巨大潜力.本文简要综述了昆虫抗菌肽对肿瘤细胞的抑制作用及其作用机制,并对其开发潜力和实际应用价值进行了展望,以期为今后的研究提供理论支持.     

昆虫抗菌肽及其基因工程研究进展

昆虫抗菌肽是昆虫免疫后存在于血淋巴中的一类活性肽,具有广谱的抗菌、抗病毒、抑制肿瘤的生物活性,具有很高的应用潜力。本文主要介绍昆虫抗菌肽的类型、生理活性、基因的克隆与表达及转基因工程研究进展。 Insect Antibacterial Peptides and Its Progress in Advance on Genetic Engineering GONG Xia,YUE Guo-wei,SHI Yong-hui Laboratory for Animal Nutrition Research,College of Food Science,Southern Yangtze University,Wuxi 214036,China Abstract:Insect antibacterial peptides produced are kinds of bioactive peptides in hameolymph hen insect has been immunized.These peptides have the wide range of antibacterial,antiviral spectrum and inhibiting growth of tumor cell.The types of antibacterial peptides and its physiological activities,cloning and expression of the genes and transgenetic research are summarized.Its application on medicine and gene engineering are prospected. Key words：insect antibacterial peptides; physiological activity; gene     

Antibacterial peptides isolated from insects.

Insects are amazingly resistant to bacterial infections. To combat pathogens, insects rely on cellular and humoral mechanisms, innate immunity being dominant in the latter category. Upon detection of bacteria, a complex genetic cascade is activated, which ultimately results in the synthesis of a battery of antibacterial peptides and their release into the haemolymph. The peptides are usually basic in character and are composed of 20-40 amino acid residues, although some smaller proteins are also included in the antimicrobial repertoire. While the proline-rich peptides and the glycine-rich peptides are predominantly active against Gram-negative strains, the defensins selectively kill Gram-positive bacteria and the cecropins are active against both types. The insect antibacterial peptides are very potent: their IC50 (50% of the bacterial growth inhibition) hovers in the submicromolar or low micromolar range. The majority of the peptides act through disintegrating the bacterial membrane or interfering with membrane assembly, with the exception of drosocin, apidaecin and pyrrhocoricin which appear to deactivate a bacterial protein in a stereospecific manner. In accordance with their biological function, the membrane-active peptides form ordered structures, e.g. alpha-helices or beta-pleated sheets and often cast permeable ion-pores. Their cytotoxic properties were exploited in in vivo studies targeting tumour progression. Although the native peptides degrade quickly in biological fluids other than insect haemolymph, structural modifications render the peptides resistant against proteases without sacrificing biological activity. Indeed, a pyrrhocoricin analogue shows lack of toxicity in vitro and in vivo and protects mice against experimental Escherichia coli infection. Careful selection of lead molecules based on the insect antibacterial peptides may extend their utility and produce viable alternatives to the conventional antimicrobial compounds for mammalian therapy.     

Design and synthesis of novel antimicrobial peptides on the basis of alpha helical domain of Tenecin 1, an insect defensin protein, and structure-activity relationship study

Tenecin 1, a peptide consisting of 43 amino acids, exhibits a potent bactericidal activity against various Gram-positive bacteria and shares a common structural feature of insect defensin family corresponding to cysteine stabilized alpha/beta motif. Our previous research indicated that an active fragment was successfully extracted from C-terminal beta sheet domain of Tenecin 1, whereas the fragment corresponding to the alpha helical region of the protein had no antibacterial activity. We chose this inactive fragment corresponding to alpha helical region of Tenecin 1 and synthesized derivatives with a different net positive charge by using rational design. Interestingly, we successfully endowed antibacterial activity as well as antifungal activity to the inactive alpha helical fragment by single or double amino acid replacement(s) without an increase of hemolytic activity. The leakage of dye from vesicles induced by the active peptides suggested that these peptides act on the membranes of pathogen as a primary mode of action. Structure-activity relationship study of a series of the active derivatives revealed that amphiphilic structure and high net positive charge were prerequisite factors for the activity and that there was a relationship between the antibacterial activity and the isoelectric point of the active peptides. In this work, we showed an efficient method to endow the antibacterial activity as well as antifungal activity to the inactive fragment derived from a cyclic insect defensin protein and suggested a facile method to screen for active fragments from cyclic host defense peptides.     

Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity

Lepidoptera have been reported to produce several antibacterial peptides in response to septic injury. However, in marked contrast to other insect groups, no inducible antifungal molecules had been described so far in this insect order. Surprisingly, also cysteine-rich antimicrobial peptides, which predominate in the antimicrobial defense of other insects, had not been discovered in Lepidoptera. Here we report the isolation from the hemolymph of immune induced larvae of the lepidopteran Heliothis virescens of a cysteine-rich molecule with exclusive antifungal activity. We have fully characterized this antifungal molecule, which has significant homology with the insect defensins, a large family of antibacterial peptides directed against Gram-positive strains. Interestingly, the novel peptide shows also similarities with the antifungal peptide drosomycin from Drosophila. Thus, Lepidoptera appear to have built their humoral immune response against bacteria on cecropins and attacins. In addition, we report that Lepidoptera have conferred antifungal properties to the well conserved structure of antibacterial insect defensins through amino acid replacements.     

抗昆虫蝎毒素及其转基因技术的研究与应用进展

本文综述了蝎毒中抗昆虫毒素成分的种类、理化性质、分子结构与功能 ,以及利用抗昆虫蝎毒素基因构建重组微生物杀虫剂和培育抗虫植物的研究与应用的进展情况 ,并就该技术对害虫防治的意义、所存在的生态安全性等问题和应对策略进行了探讨。     

新型抗菌肽——表面活性素、伊枯草菌素和丰原素

表面活性素（surfactin）、伊枯草菌素（iturin）和丰原素（fengycin）是一类主要由革兰阳性芽胞杆菌通过非核糖体合成途径产生的抗菌肽,一般是由1个β-羟基脂肪酸与7～10个氨基酸肽链以酰胺键连接而成的环肽,具有抗细菌、抗真菌、抗病毒、抗肿瘤等生物活性,在医疗方面具有良好的应用前景。目前,人们对这3种新型抗菌肽在医药领域中的研究进展所知甚少,故本文对其发现历史、结构特点、作用机制、生物合成和应用价值进行阐述,为后续研究提供借鉴。     

The inducible antibacterial peptides of insects

Insects respond to bacterial challenge by the rapid and transient synthesis of a large number of potent antibacterial peptides that are active against many different bacteria. Two families of inducible antibacterial peptides are well characterized: the cecropins and the insect defensins. A rapidly increasing number of proline- and glycine-rich peptides are reported from various insect species together with cecropins and insect defensins. In this review, Stéphane Cociancich, Philippe Bulet, Charles Hetru and Jules A. Hoffmann give an update of our current information on the induced antibacterial peptides.     

抗菌肽基因工程研究及其表达策略

抗菌肽广泛存在于多种生物体内,具有广谱抗菌、调节免疫、抑制肿瘤等多种生物学功能,作用机制独特,是目前基因工程研究的热点之一。本文综述了抗菌肽的一般性质及其国内外基因工程研究进展,探讨了在抗菌肽转基因研究中采用的表达策略及理论依据。